Assignee
CONSTELLATION PHARMACEUTICALS INC
US·33 granted patents·30 pending applications·151 citations·filing 2012–2024
Top patents by PatentIndex Score
63 records- 0197US9469646B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Oct 18, 2016·21 cites·4 claims
- 0296US9409865B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Aug 9, 2016·14 cites·3 claims
- 0393US9085583B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION—PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·18 cites·14 claims
- 0492US9051269B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2012·Granted Jun 9, 2015·9 cites·7 claims
- 0591US9969747B2Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamideCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted May 15, 2018·12 cites·13 claims
- 0691US9371331B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Jun 21, 2016·8 cites·9 claims
- 0791US9206128B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2012·Granted Dec 8, 2015·10 cites·17 claims
- 0890US10918646B1Methods of treating myeloproliferative disordersCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·30 claims
- 0990US10689371B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Jun 23, 2020·5 cites·29 claims
- 1090US9624244B2Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Apr 18, 2017·8 cites·6 claims
- 1188US11274095B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Granted Mar 15, 2022·2 cites·34 claims
- 1287US9745305B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·11 cites·17 claims
- 1387US9522920B2Bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Dec 20, 2016·10 cites·21 claims
- 1486US10016405B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jul 10, 2018·3 cites·4 claims
- 1585US9980952B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·3 cites·8 claims
- 1685US9969716B2Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted May 15, 2018·4 cites·21 claims
- 1782US11919912B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Mar 5, 2024·2 cites·18 claims
- 1880US10526287B2LSD1 inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jan 7, 2020·2 cites·22 claims
- 1978US10517849B2LSD1 inhibitors and medical uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2017·Granted Dec 31, 2019·2 cites·23 claims
- 2076US11013718B2LSD1 inhibitors and medical uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted May 25, 2021·1 cites·18 claims
- 2175US2025230137A1P300/cbp hat inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2274US2024116905A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2373US9925197B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·1 cites·5 claims
- 2473US2025136588A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2572US9493483B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·1 cites·8 claims
- 2670US11547695B2LSD1 inhibitors and medical uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2021·Granted Jan 10, 2023·0 cites·19 claims
- 2769USRE47428EModulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·4 claims
- 2868US12070464B2Methods of treating myeloproliferative disordersCONSTELLATION PHARMACEUTICALS INC·Filed 2022·Granted Aug 27, 2024·0 cites·17 claims
- 2968US10035801B2Pyrazolo compounds and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Jul 31, 2018·1 cites·15 claims
- 3066US2019125737A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3164US2015376190A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3264US2025122217A1Anhydrous crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamideCONSTELLATION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3361US2024269146A1Use of pelabresib for treating anemiasCONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3460US12172990B2Modulators of TREX1CONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Dec 24, 2024·0 cites·19 claims
- 3560US11274090B2P300/CBP HAT inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Mar 15, 2022·0 cites·24 claims
- 3657US2024246946A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3757US2026021082A1Ezh2 inhibition therapies for the treatment of at-rich interactive domain-containing protein 1a (arid1a) mutated cancersCONSTELLATION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3856US2024262814A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3955US2023414593A1Ezh2 inhibition therapies for the treatment of androgen receptor mutated prostate cancersCONSTELLATION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4053US11459315B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Granted Oct 4, 2022·0 cites·11 claims
- 4152US10457640B2Synthesis of inhibitors of EZH2CONSTELLATION PHARMACEUTICALS INC·Filed 2017·Granted Oct 29, 2019·0 cites·20 claims
- 4252US2019048048A1Fusion proteins and methods for identifying bromodomain inhibiting compoundsCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4352US2022135538A1P300/cbp hat inhibitors and methods for their useCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4451US2022331304A1Compounds for use in treating neurological disordersCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4551US2022257577A1Ezh2 inhibition in combination therapies for the treatment of cancersCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4651US2022313701A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4750US2023302010A12-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide for treating thrombocythemiaCONSTELLATION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4850US2022289728A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4948US11414384B2P300/CBP hat inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Aug 16, 2022·0 cites·20 claims
- 5048US2023233541A1Substituted benzamides as modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CONSTELLATION PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →